Urgent Recall Issued for Common Blood Pressure Medication

Got story updates? Submit your updates here. ›

Health officials have issued an urgent recall for a batch of the common blood pressure medication Ramipril, after discovering a manufacturing error resulted in some capsules containing a different medication, Amlodipine, instead. While both drugs are used to treat high blood pressure, the accidental substitution could lead to side effects like dizziness from lower than normal blood pressure in some patients.

Why it matters

Medication recalls, while not uncommon, can be concerning for patients who rely on these drugs to manage their health conditions. This particular recall highlights the importance of quality control in pharmaceutical manufacturing and the need for patients to be vigilant about checking their medications, especially when changes occur.

The details

The affected batch is Ramipril 5 mg capsules with Batch Number GR164099, produced by Crescent Pharma Limited. The issue is that some of the blister strips in this batch actually contain Amlodipine 5 mg tablets instead of the labeled Ramipril. While both medications treat high blood pressure, the unintended substitution could lead to side effects like dizziness in some patients.

• The recall was issued on March 12, 2026 by health officials.

What they’re saying

What’s next

Patients who have the affected batch of Ramipril 5 mg capsules should check the packaging, and if it matches the recalled batch, contact their pharmacy. Those experiencing any side effects should seek medical advice immediately.